ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION

Executive Summary

• The Board approved a 1‑for‑10 reverse split of Else Nutrition’s common shares, reducing the share count from ~374 M to ~37.4 M.
• Post‑consolidation shares will begin trading on the Toronto Stock Exchange under the same ticker “BABY” at market open on November 6, 2025 with new CUSIP and ISIN numbers.
• All outstanding stock options, warrants, and convertible securities will be proportionally adjusted; fractional shares will be rounded according to the described rules.

Key Details

• Consolidation Ratio: 1 post‑consolidation share for every 10 pre‑consolidation shares.
• Effective Trading Date: Market opening on November 6, 2025 (TSX).
• New Identifiers: CUSIP 290257500; ISIN CA2902575000.
• Share Count Reduction: From 374,114,284 to approximately 37,411,430 shares (subject to rounding adjustments).
• Adjustments: Stock options, warrants, and other convertible securities will be proportionally adjusted to reflect the new share count.
• Fractional Share Treatment: Fractions < 0.5 of a share are rounded down; fractions ≥ 0.5 are rounded up. No fractional shares will be issued.
• Shareholder Process – Certified Holders: Receive a transmittal letter from Computershare Investor Services to surrender pre‑consolidation certificates and receive DRS for post‑consolidation shares.
• Shareholder Process – DRS Holders: Automatic issuance of post‑consolidation DRS; no action required.
• Intermediary Holders: Must follow their broker/intermediary’s procedures for the consolidation.
• Warrant Holders Notification: Holders of warrants issued on Oct 20, 2021 and Jun 29, 2022 will receive notices per the respective Warrant Indentures.

Notable Quotes

(No executive quotes were included in the release.)